Home ›
News ›
Archives

June 2018

Notre Dame technology licensed worldwide: Hsiri Therapeutics enters into a license and research collaboration agreement with Shionogi &Co., Ltd. for the treatment of mycobacterial diseases

June 28, 2018

University of Notre Dame licensee Hsiri Therapeutics, Inc., with its corporate headquarters located in Media, PA, has entered into a license agreement with Shionogi & Co., Ltd. regarding a collaborative licensing, research and development program to…

New Hope for the Treatment of Diabetic Foot Ulcers

June 27, 2018

In America, more than a million people suffer from diabetic foot ulcers.

In Latin, SalvePeds means “saving feet.”

And in SalvePeds, a new IDEA Center startup managed and marketed by a team of graduate students at the University of Notre Dame, patients may soon…